TuHURA Biosciences Inc. (HURA)
4.62
0.03 (0.65%)
At close: Jan 15, 2025, 12:00 PM
undefined% (undefined)
| Bid | 4.59 |
| Market Cap | 195.35M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -12.49 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 4.65 |
| Volume | 70,100 |
| Avg. Volume (20D) | 314,244 |
| Open | 4.66 |
| Previous Close | 4.59 |
| Day's Range | 4.60 - 4.90 |
| 52-Week Range | 2.83 - 14.60 |
| Beta | undefined |
About HURA
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL....
Industry Biotechnology
Sector Healthcare
IPO Date Feb 22, 2013
Employees 11
Stock Exchange NASDAQ
Ticker Symbol HURA
Website http://www.tuhurabio.com
Analyst Forecast
According to 1 analyst ratings, the average rating for HURA stock is "Buy." The 12-month stock price forecast is $11, which is an increase of 138.10% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
